Sionna Therapeutics, Inc. (SION) vs Entrada Therapeutics, Inc. (TRDA)
A side-by-side comparison of Sionna Therapeutics, Inc. and Entrada Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SION
Sionna Therapeutics, Inc.
$4.62HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
TRDA
Entrada Therapeutics, Inc.
$5.41HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — SION vs TRDA
growth of $100 · dividends reinvested · last 2ySION -80.6% (-56.0%/yr)TRDA -59.3% (-36.2%/yr)TRDA compounded faster over this window
SION TRDA
SION vs TRDA: by the numbers
- •TRDA is the larger company ($210M vs $209M market cap).
- •Both run net losses; SION's is the smaller (0.00% vs -3537.73% net margin).
Metrics side by side
Valuation
| Metric | SION | TRDA |
|---|---|---|
| P/S ratio | N/A | 44.82 |
| P/B ratio | 0.78 | 0.90 |
Profitability
| Metric | SION | TRDA |
|---|---|---|
| Gross margin | 0.00% | 83.89% |
| Operating margin | 0.00% | -613.66% |
| Net margin | 0.00% | -3537.73% |
| ROE | -36.64% | -71.02% |
| ROIC | -40.18% | -63.61% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.